If you could vote on Brexit now which option would you choose?

Novavax COVID shot, aimed at vaccine skeptics, overwhelmingly backed by FDA panel

Advisers to the U.S. Food and Drug Administration on Tuesday voted overwhelmingly to recommend that the agency authorize Novavax Inc's (NVAX.O) COVID-19 vaccine for use in adults, which the drugmaker hopes can become the shot of choice among some American vaccine skeptics. The panel of outside vaccine experts voted 21-0 with one abstention in favor of the vaccine for those 18 and older after discussing whether the shot's benefits outweigh risks, including rare occurrences of heart inflammation that may be associated with the vaccine.

Reuters - June 8, 2022

View the full story here: https://www.reuters.com/world/us/novavax-covid-vaccine-heads-us-fda-advisory-committee-2022-06-07/